Protagonist Therapeutics Inc (PTGX)

Current ratio

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Total current assets US$ in thousands 627,553 355,577 324,881 316,941 235,736 243,077 276,617 304,302 341,522 340,736 327,687 371,818 285,508 315,606 204,151 217,466 125,986 145,311 144,023 137,320
Total current liabilities US$ in thousands 39,910 21,274 27,867 26,398 23,229 31,179 36,754 40,088 43,456 44,016 39,156 42,973 34,515 40,241 38,563 35,360 36,372 35,406 30,776 33,323
Current ratio 15.72 16.71 11.66 12.01 10.15 7.80 7.53 7.59 7.86 7.74 8.37 8.65 8.27 7.84 5.29 6.15 3.46 4.10 4.68 4.12

March 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $627,553K ÷ $39,910K
= 15.72

The current ratio of Protagonist Therapeutics Inc has shown a generally positive trend over the past few quarters, indicating the company's ability to meet its short-term obligations with its current assets. The ratio has consistently remained above 1, indicating that the company has more than enough current assets to cover its current liabilities.

There has been a notable increase in the current ratio from the end of 2019 to the latest quarter of 2024, with the ratio peaking at 16.71 in December 2023. This suggests that the company has significantly strengthened its liquidity position over this period. However, it's important to note that the ratio has fluctuated somewhat, reaching its lowest point of 3.46 in March 2020, although it has since recovered and remained relatively stable.

Overall, the current ratio of Protagonist Therapeutics Inc demonstrates sound liquidity management and a healthy balance between current assets and liabilities, indicating a strong financial position to support its operations and growth.


Peer comparison

Mar 31, 2024